Eisai Plans R&D Revamp To Turn The Development Tide
This article was originally published in The Pink Sheet Daily
Executive Summary
Six autonomous product creation units to focus on neuroscience, oncology, antibodies and immunological anti-inflammatory diseases, with units also focused on late stage drugs and Japanese clinical research.